Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more

TSX:LABS - Post Discussion

View:
Post by allibabba on Jan 10, 2022 4:23pm

Tilray

Tilray released earnings today and has the biggest piece of the German medical cannabis business.  I don't know what these idiots are up to but the fact they call themselves a global leader in the medical space is complete bullroar.  Get you act together and do something for the love of god!  I would vote yes in an instant for a buyout at .60 per share.  This company is pathetic.
Comment by mdjbrown on Jan 10, 2022 7:30pm
Theres a cure for what ails you allibabba If you actually hold Labs shares its called sell your shares and move on, instead of whining about what you have no control over. Those running the show have a strategy in place and I hate to say,  your armchair critique is irrelevant to their strategy. Find a company you think is better, and walla, problem solved  ........We have all been ...more  
Comment by Starkicker on Jan 11, 2022 3:23pm
As a shareholder there are legit reasons to be concerned about this company. Their financing was a disaster, they got their butts whipped badly by Valens in the domestic market, Australia isn't living up to expectations, and international revenues are less than a mediocre NHL player's annual salary. 2022 will be a very telling year for this company... if revenue isn't firing on at ...more  
Comment by Redwine12345 on Jan 12, 2022 10:45am
And yet, Tilray is down from $27 to $9.  Suck it up buddy... It 's called sector trend.... 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities